echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Multi-local hospitals frequently report the tide, forcing the drug industry compliance development

    Multi-local hospitals frequently report the tide, forcing the drug industry compliance development

    • Last Update: 2020-11-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "Pharmaceutical Network Industry Dynamics" in September, Anhui, Shandong, Hebei and other hospitals to reproduce the reporting tide, these "report letter" content is about the same, directly refers to some departments (including surgery and internal medicine) doctors and pharmaceutical representatives have abnormal sales relations, that is, with gold sales problems.
    behind this series of actions, the entire pharmaceutical representative industry is being pushed towards compliance.
    , what are the frequent reports of medical representatives? According to industry insiders, many whistleblowers behind the purpose is also diverse, some do exist violations, peer reporting;
    under the background of the normalization of drug collection and medical reform negotiations, the price war has intensified, whether it is generic drugs or innovative drugs, and the profit margin has been further reduced, which has intensified competition.
    some pharmaceutical companies may choose to give their agents and marketing staff in order to obtain higher profits, take away low prices and high rates, and instigated sales staff to go to medical institutions to promote the sale of gold, commercial bribery.
    The State Health Insurance Administration's Guidance on the Establishment of a Drug Price and Recruitment Credit Evaluation System (Draft for Comments) shows that pharmaceutical enterprises, while promising to put an end to commercial bribery and market manipulation, should also undertake to entrust service enterprises, agency enterprises for their own drug commercial bribery, market manipulation and other illegal acts, with a number of price and credit disciplinary responsibilities.
    For the pharmaceutical industry, the formal reporting of the improper interests of pharmaceutical representatives can further curb the improper trend in the field of pharmaceutical purchase and sale from the source, and standardize the marketing behavior of pharmaceutical suppliers and their pharmaceutical business personnel.
    In fact, in response to improper behavior in the pharmaceutical industry, such as gold sales, on June 5 this year, the National Health and Wellness Commission and other nine departments released the "2020 correction of the field of pharmaceutical purchase and sale and medical services in the field of improper work points" (hereinafter referred to as "key points") in the document stressed that serious investigation and prosecution of the collection of pharmaceutical supplies enterprise rebate behavior.
    "Key Points" also made it clear that by the end of the year, led by the National Health and Health Commission, member units in accordance with the division of responsibilities to cooperate, regulate the way of cooperation and exchanges between medical and commercial.
    the bottom line of behavior between trade associations, medical institutions and pharmaceutical-related enterprises, and formulate norms for medical personnel's conduct in foreign exchanges.
    Then, on July 24th, the Special Action Plan for the Construction of Style in the Medical Industry 2020 was officially launched, which made it clear that from July to December, the special corrective action for the construction of style in the medical industry would be implemented in three stages.
    this context, a number of places have also issued relevant notifications.
    , for example, the Shanghai Health and Safety Commission recently issued a special rectification policy related to the construction of the style of the medical industry, which will last for 3 months (September-December 2020).
    The Shanghai Health and Safety Commission pointed out in the rectification document that through letters and visits, reports, departmental collaboration and other channels to reflect the clues, focusing on the examination of all types of medical institutions at all levels of practitioners (including doctors, nurses, medical technicians, administrative personnel) to take advantage of the convenience of their duties, in medical activities (including The illegal acts of soliciting or receiving "red envelope" gifts or other improper benefits from patients and their families in various names shall be punished according to the seriousness of the circumstances and notified throughout the industry.
    Overall, the current multi-policy overlay of volume procurement, tax verification, medical correction, etc., the construction of the trend is becoming stricter, the rules of pharmaceutical marketing have been changed, and the traditional marketing model of pharmaceutical companies is being affected.
    , pharmaceutical representatives need to return to their essence, focusing on purely academic promotion and increasing compliance and safety awareness.
     
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.